NasdaqGS - Delayed Quote USD
IGM Biosciences, Inc. (IGMS)
1.2600
-0.0100
(-0.79%)
At close: June 2 at 4:00:02 PM EDT
1.2890
+0.03
+(2.30%)
After hours: June 2 at 5:57:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-143,098
-152,996
-192,231
-5,853
-124,982
Investing Cash Flow
98,243
64,158
68,355
-225,644
15,461
Financing Cash Flow
2,241
2,388
115,068
219,382
2,476
End Cash Position
36,884
26,662
113,112
121,920
134,035
Income Tax Paid Supplemental Data
--
0
625
0
0
Capital Expenditure
-3,399
-5,852
-12,381
-10,206
-13,244
Issuance of Capital Stock
--
0
113,564
217,987
0
Free Cash Flow
-146,497
-158,848
-204,612
-16,059
-138,226
12/31/2021 - 9/18/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACRV Acrivon Therapeutics, Inc.
1.1100
+5.71%
ALXO ALX Oncology Holdings Inc.
0.5587
+15.08%
OLMA Olema Pharmaceuticals, Inc.
4.3750
-17.14%
LXEO Lexeo Therapeutics, Inc.
2.7200
0.00%
ANTX AN2 Therapeutics, Inc.
1.0600
0.00%
PYXS Pyxis Oncology, Inc.
1.2200
+0.83%
RLYB Rallybio Corporation
0.2862
-7.38%
KURA Kura Oncology, Inc.
6.30
+10.72%
ARTV Artiva Biotherapeutics, Inc.
1.9400
+0.52%
IDYA IDEAYA Biosciences, Inc.
21.22
+6.69%